Stocks and Investing Stocks and Investing
Thu, August 11, 2022
Wed, August 10, 2022

Gena Wang Maintained (BEAM) at Hold with Increased Target to $60 on, Aug 10th, 2022


Published on 2024-10-27 22:34:13 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Increased Target from $38 to $60 on, Aug 10th, 2022.

Gena has made no other calls on BEAM in the last 4 months.



There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, all agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kostas Biliouris of "BMO Capital" Initiated at Hold and Held Target at $41 on, Friday, June 17th, 2022
  • Richard Law of "Credit Suisse" Initiated at Hold and Held Target at $62 on, Thursday, April 28th, 2022